250683-76-2 Usage
Uses
Used in Pharmaceutical Industry:
3-Fluoro-4-(4-methyl-1-piperazinyl)benzoic Acid is utilized as a key intermediate in the synthesis of drugs for the treatment of psychiatric disorders and neurological conditions. Its chemical structure allows for potential modulation of neurotransmitter receptor activity, which is crucial for managing such conditions.
Used in Drug Development:
As a pharmaceutical compound, 3-Fluoro-4-(4-methyl-1-piperazinyl)benzoic Acid is used in the development of new drugs that aim to treat a range of psychiatric and neurological disorders. Its potential to interact with neurotransmitter receptors positions it as a candidate for further exploration in drug discovery and medicinal chemistry.
Used in Research and Testing:
3-Fluoro-4-(4-methyl-1-piperazinyl)benzoic Acid serves as a subject for research and testing in laboratories to understand its pharmacological properties. This includes evaluating its interactions with neurotransmitter receptors and assessing its safety and efficacy in potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 250683-76-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,0,6,8 and 3 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 250683-76:
(8*2)+(7*5)+(6*0)+(5*6)+(4*8)+(3*3)+(2*7)+(1*6)=142
142 % 10 = 2
So 250683-76-2 is a valid CAS Registry Number.
250683-76-2Relevant academic research and scientific papers
PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
-
Paragraph 1995; 1997; 1998, (2016/08/03)
The invention relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula: where m, n, X1, X2, R1-R5, R5′ and R6 are described herein.
TROPANE COMPOUNDS
-
Page/Page column 370, (2009/05/30)
A compound according to Formula I or II: (I) or (II) wherein R1, R1b, R2, L1, and L2 and L2b are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
